Current and Promising Antivirals Against Chikungunya Virus
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever (CHIKF) and is categorized as a(n) (re)emerging arbovirus. CHIKV has repeatedly been responsible for outbreaks that caused serious economic and public health problems in the affected countries. To date, no vaccine or specific anti...
Saved in:
Main Authors: | Friederike I. L. Hucke (Author), Joachim J. Bugert (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023) -
Antiviral Activity of Oridonin Against Herpes Simplex Virus Type 1
by: Jiang K, et al.
Published: (2022) -
Current Topics in Chikungunya
Published: (2016) -
Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
by: Li Wei Ang, et al.
Published: (2017) -
Novel antiviral activity of baicalein against dengue virus
by: Zandi Keivan, et al.
Published: (2012)